WEANING OF IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS 12

[1]  D. V. van Thiel,et al.  Evolution of Liver Transplantation , 2007, Hepatology.

[2]  T. Starzl,et al.  The lost chord: microchimerism and allograft survival. , 1996, Immunology today.

[3]  T. Howard,et al.  Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. , 1996, Transplantation.

[4]  J. Neuberger,et al.  Timing, significance, and prognosis of late acute liver allograft rejection. , 1995, Transplantation.

[5]  C. Delaney,et al.  Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. , 1995, Transplantation.

[6]  A. Demetris,et al.  Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. , 1995, The American journal of surgical pathology.

[7]  T. Starzl,et al.  Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. , 1995, Transplantation proceedings.

[8]  T. Starzl,et al.  Weaning Of Immunosuppression In Long‐Term Liver Transplant Recipients , 1995, Transplantation.

[9]  G. Gores,et al.  Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection , 1994, Hepatology.

[10]  T. Starzl,et al.  Murine liver allograft transplantation: Tolerance and donor cell chimerism , 1994, Hepatology.

[11]  H. Schlitt,et al.  Donor-type microchimerism associated with graft rejection eight years after liver transplantation. , 1994, The New England journal of medicine.

[12]  T. Starzl,et al.  Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. , 1993, Transplantation proceedings.

[13]  T. Starzl,et al.  Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance , 1993, Hepatology.

[14]  T. Starzl,et al.  Cell migration, chimerism, and graft acceptance , 1992, The Lancet.

[15]  D. V. van Thiel,et al.  CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTS , 1992, Transplantation.

[16]  R. Wiesner,et al.  Severe Ductopenic Rejection Following Liver Transplantation: Incidence, Time of Onset, Risk Factors, Treatment, and Outcome , 1992, Seminars in liver disease.

[17]  T. Starzl,et al.  Fifteen years of clinical liver transplantation. , 1979, Gastroenterology.

[18]  T. Starzl,et al.  FK 506 for human liver, kidney, and pancreas transplantation , 1989 .